bioMérieux is now supplying the QuickVue range of rapid diagnostic tests worldwide, as part of a long-term global alliance with Quidel for the development and distribution of rapid clinical diagnostic solutions.
Offering fast and cost-effective clinical solutions for point-of-care diagnostic testing, the QuickVue range of rapid diagnostics tests brings proven quality and reactivity to the detection of infectious diseases. The QuickVue range includes qualitative detection of influenza type A and type B antigens, a dipstick immunoassay for acute respiratory syncytial virus (RSV) infections and a one-step human chorionic gonadotrophin (hCG) test, as well as quick and simple tests for Helicobacter pylori, Chlamydia and group A streptococcal infections.
In addition, many new tests are in the development pipeline, combining Quidel’s rapid testing capabilities with bioMérieux’s expertise in immunochemistry and its extensive library of biologicals.
www.biomerieux.com